The U.S. Food and Drug Administration has approved Advanced Cell Technology's investigational new drug application to launch the first clinical trial using retinal cells derived from human embryonic stem cells for treating Stargardt's macular dystrophy, the company announced in a press release, which appeared on theOSNSuperSite.
No comments:
Post a Comment